The global market for GLP-1 receptor agonists has a surge in demand due to their effectiveness in managing type 2 diabetes. Several pharmaceutical companies have received FDA approval to manufacture these life-changing medications. {Novo Nordisk|Eli Lillyis a leading manufacturer of GLP-1 receptor agonists, with highly regarded products like We